A new daily injection for children with growth hormone deficiency
Part of Bones, joints & muscles, Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests a new growth hormone injection (GB08) to see if it helps children with growth hormone deficiency grow taller. If your child is diagnosed with this condition and hasn't yet tried growth hormone treatment, they might benefit from participating.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 3 and 10 years old (for girls) or 11 years old (for boys).
- Your child must have a confirmed diagnosis of growth hormone deficiency.
- Your child must be shorter than most children their age and growing slowly.
- Your child must not have had prior growth hormone or sex hormone treatment.
- Your child must not have other conditions that cause short stature (like Turner syndrome or chronic illness).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new growth hormone medicine (GB06) for children whose bodies don't make enough growth hormone naturally. The study will see if this treatment helps children grow taller over time.
This study looks at whether consistently taking growth hormone (Norditropin) helps children reach a height goal by “near final height.” It focuses on children who are short due to growth hormone deficiency or born small for gestational age.
This trial tests a new medicine called LUM-201 for children who haven't grown enough because their bodies don't make enough growth hormone. It aims to help kids who haven't been treated before and are still at an early stage of puberty.
This study tests a new once-a-week injection (GenSci134) for children with growth hormone deficiency. It aims to see if it is safe and helps them grow. Your child may be able to join if they have not been treated before and meet the age and height requirements.
This trial is testing an experimental growth hormone treatment for children who are short for their age but otherwise healthy. Participation may help determine if the treatment can safely improve growth.
This trial tests a new growth hormone treatment called GenSci134 in healthy adults and adults with growth hormone deficiency (AGHD). The goal is to see if it is safe and effective for people who need growth hormone replacement.
Hear when a new Growth Hormone Deficiency in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.